Virginia Retirement Systems’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.37M Buy
136,800
+32,300
+31% +$355K 0.01% 427
2023
Q2
$1.3M Buy
104,500
+30,700
+42% +$414K 0.01% 469
2023
Q1
$1.03M Buy
73,800
+18,800
+34% +$270K 0.01% 539
2022
Q4
$787K Buy
55,000
+17,400
+46% +$274K 0.01% 679
2022
Q3
$960K Buy
+37,600
New +$943K 0.01% 587
2022
Q1
$1.11M Buy
31,400
+2,300
+8% +$77.1K 0.01% 605
2021
Q4
$1.22K Buy
29,100
+12,800
+79% +$519K 0.01% 591
2021
Q3
$800K Buy
+16,300
New +$795K 0.01% 669

Other funds holding MRVI

Virginia Retirement Systems's MRVI Position: Q3 2023 in Review

Virginia Retirement Systems increased its Maravai LifeSciences (MRVI) stake by 31% in Q3 2023, buying an estimated $355K and bringing the position to 136,800 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #427.

Virginia Retirement Systems first reported a position in MRVI in Q3 2021 and has held it in 8 quarters since. 204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

  • Virginia Retirement Systems held 136,800 shares of Maravai LifeSciences worth $1.37M as of Q3 2023.
  • Virginia Retirement Systems bought 32,300 Maravai LifeSciences shares in Q3 2023, an estimated $355K.
  • Maravai LifeSciences made up 0.01% of Virginia Retirement Systems's portfolio in Q3 2023, its #427 holding.
  • Virginia Retirement Systems first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 8 quarters since.
  • 204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.